Phascolarctobacterium

A Gram-negative, obligate anaerobic genus within the Firmicutes phylum (family Acidaminococcaceae, class Negativicutes). The primary species P. faecium and the recently characterized P. succinatutens are specialized propionate producers that utilize succinate as their main carbon source, occupying a unique metabolic niche in the cross-feeding network of the human colon. Named after its original isolation from koala feces, Phascolarctobacterium has emerged as a protective commensal in autoimmune and metabolic disease contexts — though with notable exceptions in psychiatric conditions.

Classification and Ecology

The Negativicutes class within Firmicutes is distinctive: these organisms stain Gram-negative despite being phylogenetically Gram-positive. Phascolarctobacterium shares this class with Veillonella, Selenomonas, and Dialister — all succinate utilizers or SCFA producers occupying specialized metabolic niches. P. faecium is the dominant species in human adults; P. succinatutens was described in 2012 and is present in subset of healthy individuals.

Role in Gut Ecosystem — The Succinate Cross-Feeding Niche

The defining ecological feature of Phascolarctobacterium is its role as a second-tier cross-feeder in the colonic fermentation network:

1. Primary fermenters (bacteroides fragilis, parabacteroides, and other Bacteroidetes) ferment complex carbohydrates and produce succinate as an intermediate metabolic product.
2. Phascolarctobacterium converts succinate to propionate via the methylmalonyl-CoA decarboxylase pathway — a sodium-gradient-coupled mechanism distinct from the acrylate pathway used by other propionate producers.
3. By consuming succinate, it prevents succinate accumulation, which at high concentrations:

• Acts as a pro-inflammatory signal via SUCNR1 (GPR91) receptor activation
• Promotes HIF-1α stabilization and macrophage activation in gut tissue
• Creates a metabolic environment that favors pathogen expansion

1. The resulting propionate:

• Signals through GPR43 (free fatty acid receptor 2) to promote Treg differentiation
• Contributes to hepatic gluconeogenesis regulation and lipid metabolism suppression
• Reduces histone deacetylase activity, exerting epigenetic anti-inflammatory effects

This cross-feeding function means Phascolarctobacterium abundance is indirectly controlled by dietary patterns that regulate upstream Bacteroidetes activity — it is a second-order fiber responder.

Metal Dependencies

No essential metal dependencies specific to the succinate-to-propionate pathway have been confirmed for Phascolarctobacterium. The methylmalonyl-CoA decarboxylase enzyme uses biotin as a cofactor. This absence of heavy metal dependency is notable — unlike iron-dependent fermenters, Phascolarctobacterium may be relatively resilient to the metal-driven dysbiosis that disrupts iron-sulfur-cluster-dependent organisms.

Key Enzymes and Metabolites

Enzyme / Metabolite	Function
Methylmalonyl-CoA decarboxylase	Core succinate → propionate conversion; biotin-dependent, sodium-pumping
Propionate	GPR43 ligand; Treg promoter; anti-inflammatory; hepatic metabolic regulator
Succinate (consumed)	Prevents SUCNR1 inflammatory signaling; removes pathogen-favorable substrate

Disease Associations

Graves' Disease — Protective

Phascolarctobacterium is identified as a protective taxon in graves disease through multiple lines of evidence:

• Mendelian randomization analysis supports a causal protective role ^[1].
• Propionate production by Phascolarctobacterium promotes Treg differentiation via GPR43 signaling, counteracting the Th17/Treg imbalance that drives GD pathogenesis.
• Depleted in untreated GD patients alongside other SCFA-producing commensals ^[2].
• After methimazole treatment and thyroid function recovery, Phascolarctobacterium increases significantly, establishing it as a biomarker of thyroid function restoration ^[3]. Concurrently, Ruminococcus, Streptococcus, and Blautia decrease — suggesting that propionate-producing Negativicutes recover as immune normalization proceeds.
• Negatively correlated with TRAb (thyroid receptor antibody), TGAb, and TPOAb in untreated GD, supporting a direct immunomodulatory link ^[3].

Hypertension — Depleted by Disease

Hypertension causally decreases Phascolarctobacterium abundance in reverse Mendelian randomization — listed alongside Alistipes, Bilophila, and Butyricomonas as taxa reduced by hypertensive disease state ^[4]. This is consistent with propionate's established role in renin-angiotensin system modulation and blood pressure regulation.

Autism Spectrum Disorder — Context-Dependent

Depletion in ASD children with constipation, consistent with the broader loss of SCFA producers in constipation-predominant ASD; lower propionate may contribute to reduced Treg activity and gut-brain axis disruption ^[5].

Schizophrenia — Enriched (Paradox)

P. succinatutens is enriched in schizophrenia patients in shotgun metagenomic analysis, alongside Paraprevotella clara (another succinate-pathway organism) ^[6]. This is paradoxical given the protective associations in autoimmune and cardiovascular conditions, and may reflect:

• Elevated succinate availability in the SCZ gut (from altered fermentation) providing substrate for P. succinatutens enrichment
• Species-level differences between P. faecium (depleted in autoimmunity) and P. succinatutens (enriched in SCZ)
• Disrupted downstream propionate signaling in SCZ — propionate produced but not properly utilized in a neuroinflammatory context

This SCZ enrichment alongside succinate pathway bacteria (when butyrate producers are depleted) suggests a shift in fermentation equilibrium rather than a beneficial enrichment.

Endometriosis — Differential Abundance

Identified among differentially abundant taxa in endometriosis stool microbiome signatures, with significant difference noted alongside Blautia, Dorea, Bifidobacterium, Streptococcus, Bacteroides, and Subdoligranulum ^[7], ^[8]. The direction of change in endometriosis is context-dependent; reduced propionate production in endometriosis may contribute to the inflammatory milieu and estrogen dysregulation characteristic of the condition.

Dietary Modulation

The succinate-to-propionate cross-feeding niche makes Phascolarctobacterium sensitive to diet through an indirect mechanism:

• Mediterranean diet enriches Phascolarctobacterium through increased availability of complex carbohydrates that promote succinate-producing Bacteroidetes, which in turn feed Phascolarctobacterium.
• High-fiber diets generally support the succinate cross-feeding network, though the effect is indirect and dependent on upstream Bacteroidetes proliferation.
• Western diet (high fat, low fiber) depletes upstream succinate producers, indirectly starving Phascolarctobacterium.
• This fiber-indirect dependency means that prebiotic interventions targeting Phascolarctobacterium should focus on Bacteroidetes-promoting fiber types (pectin, inulin) rather than direct substrate provision.

What Wikipedia Doesn't Cover

Wikipedia does not have a Phascolarctobacterium page. This page provides the first structured characterization of its succinate-to-propionate cross-feeding mechanism with clinical disease associations, including the methimazole treatment recovery marker data, the paradoxical schizophrenia enrichment, and the distinction between its protective (P. faecium) and potentially pathological (P. succinatutens) species.

Key Sources

• ^[1] — MR evidence for protective role in Graves'
• ^[3] — methimazole recovery biomarker; TRAb correlation
• ^[6] — P. succinatutens enrichment in SCZ
• ^[4] — depletion by hypertension (reverse MR)

Cross-References

• graves disease — protective via MR evidence; increases after methimazole treatment
• bacteroides fragilis — upstream cross-feeding partner; provides succinate substrate
• parabacteroides — another upstream succinate source in the cross-feeding network
• short chain fatty acids — specialized propionate producer via succinate pathway
• autism spectrum disorder — depleted in constipation-predominant ASD
• schizophrenia — P. succinatutens paradoxically enriched in SCZ patients
• endometriosis — differentially abundant in endometriosis stool signatures
• cardiovascular disease — propionate effects on blood pressure; depleted by hypertension
• inflammation — anti-inflammatory via propionate-GPR43-Treg axis; prevents succinate-SUCNR1 signaling
• faecalibacterium prausnitzii — fellow SCFA producer; complementary butyrate production
• dysbiosis — depletion indicates disrupted cross-feeding networks; restoration parallels immune recovery